Aimei Health Technology Co., Ltd (NASDAQ:AFJK – Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,900 shares, an increase of 35.7% from the December 15th total of 1,400 shares. Based on an average daily trading volume, of 54,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.
Aimei Health Technology Price Performance
Shares of AFJK stock opened at $10.80 on Friday. Aimei Health Technology has a 12-month low of $10.15 and a 12-month high of $10.85. The business has a 50 day simple moving average of $10.64 and a 200 day simple moving average of $10.52.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Rivernorth Capital Management LLC grew its position in Aimei Health Technology by 9.1% in the 3rd quarter. Rivernorth Capital Management LLC now owns 172,789 shares of the company’s stock valued at $1,811,000 after buying an additional 14,391 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Aimei Health Technology during the third quarter valued at approximately $123,000. Glazer Capital LLC increased its stake in shares of Aimei Health Technology by 3.4% during the third quarter. Glazer Capital LLC now owns 608,670 shares of the company’s stock valued at $6,379,000 after acquiring an additional 19,896 shares during the period. Mizuho Securities USA LLC raised its holdings in Aimei Health Technology by 60.7% during the third quarter. Mizuho Securities USA LLC now owns 442,778 shares of the company’s stock worth $4,627,000 after purchasing an additional 167,223 shares in the last quarter. Finally, Wolverine Asset Management LLC lifted its position in Aimei Health Technology by 8.6% in the third quarter. Wolverine Asset Management LLC now owns 539,039 shares of the company’s stock worth $5,649,000 after purchasing an additional 42,843 shares during the period. Institutional investors own 45.58% of the company’s stock.
About Aimei Health Technology
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
See Also
- Five stocks we like better than Aimei Health Technology
- What is the Australian Securities Exchange (ASX)
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Bank Stocks – Best Bank Stocks to Invest In
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.